The hypoxia-activated prodrug carbonic anhydrase IX inhibitors (HAP-CAIs) reported here were assayed using the CO2 hydrase assay against three physiologically relevant human CA isoforms, the cytosolic hCA I and II and the transmembrane, tumor-associated hCA IX (Table 1) [32]. The gene discussed is CYP24A1; the disease is neoplasm.